Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway

This research investigated if pitavastatin (Pita) might protect rats’ kidneys against thioacetamide (TAA). By altering the PTEN/AKT/mTOR pathway, pitavastatin may boost kidney antioxidant capacity and minimize oxidative damage. Statins have several benefits, including antioxidant and anti-inflammato...

Full description

Saved in:
Bibliographic Details
Main Authors: Marawan A. Elbaset, Bassim M. S. A. Mohamed, Passant E. Moustafa, Tuba Esatbeyoglu, Sherif M. Afifi, Alyaa F. Hessin, Sahar S. Abdelrahman, Hany M. Fayed
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Advances in Pharmacological and Pharmaceutical Sciences
Online Access:http://dx.doi.org/10.1155/2024/6681873
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559586021736448
author Marawan A. Elbaset
Bassim M. S. A. Mohamed
Passant E. Moustafa
Tuba Esatbeyoglu
Sherif M. Afifi
Alyaa F. Hessin
Sahar S. Abdelrahman
Hany M. Fayed
author_facet Marawan A. Elbaset
Bassim M. S. A. Mohamed
Passant E. Moustafa
Tuba Esatbeyoglu
Sherif M. Afifi
Alyaa F. Hessin
Sahar S. Abdelrahman
Hany M. Fayed
author_sort Marawan A. Elbaset
collection DOAJ
description This research investigated if pitavastatin (Pita) might protect rats’ kidneys against thioacetamide (TAA). By altering the PTEN/AKT/mTOR pathway, pitavastatin may boost kidney antioxidant capacity and minimize oxidative damage. Statins have several benefits, including antioxidant and anti-inflammatory characteristics. The principal hypothesis of this study was that Pita can regulate the miR-93/PTEN/AKT/mTOR pathways, which is thought to be responsible for its renoprotective effects. The experiment divided male rats into four groups. Group 1 included untreated rats as the control. Group 2 included rats which received TAA (100 mg/kg intraperitoneally thrice a week for two weeks) to destroy their kidneys. Groups 3 and 4 included rats which received Pita orally at 0.4 and 0.8 mg/kg for 14 days after TAA injections. Renal injury increased BUN, creatinine, and MDA levels and decreased glutathione (GSH) levels. Pitavastatin prevented these alterations. TAA decreased PTEN and increased miR-93, Akt, p-Akt, mTOR, and Stat3 in the kidneys. Pitavastatin also regulated the associated culprit pathway, miR-93/PTEN/Akt/mTOR. In addition, TAA induced adverse effects on the kidney tissue, which were significantly ameliorated by pitavastatin treatment. The findings suggest that pitavastatin can attenuate renal injury, likely by regulating the miR-93/PTEN/Akt/mTOR pathway. This modulation of the pathway appears to contribute to the protective effects of pitavastatin against TAA-induced renal injury, adding to the growing evidence of the pleiotropic benefits of statins in renal health.
format Article
id doaj-art-d1493fa405fb43029a9c61767685786b
institution Kabale University
issn 2633-4690
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological and Pharmaceutical Sciences
spelling doaj-art-d1493fa405fb43029a9c61767685786b2025-02-03T01:29:46ZengWileyAdvances in Pharmacological and Pharmaceutical Sciences2633-46902024-01-01202410.1155/2024/6681873Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR PathwayMarawan A. Elbaset0Bassim M. S. A. Mohamed1Passant E. Moustafa2Tuba Esatbeyoglu3Sherif M. Afifi4Alyaa F. Hessin5Sahar S. Abdelrahman6Hany M. Fayed7Department of PharmacologyDepartment of PharmacologyDepartment of PharmacologyDepartment of Molecular Food Chemistry and Food DevelopmentPharmacognosy DepartmentDepartment of PharmacologyDepartment of PathologyDepartment of PharmacologyThis research investigated if pitavastatin (Pita) might protect rats’ kidneys against thioacetamide (TAA). By altering the PTEN/AKT/mTOR pathway, pitavastatin may boost kidney antioxidant capacity and minimize oxidative damage. Statins have several benefits, including antioxidant and anti-inflammatory characteristics. The principal hypothesis of this study was that Pita can regulate the miR-93/PTEN/AKT/mTOR pathways, which is thought to be responsible for its renoprotective effects. The experiment divided male rats into four groups. Group 1 included untreated rats as the control. Group 2 included rats which received TAA (100 mg/kg intraperitoneally thrice a week for two weeks) to destroy their kidneys. Groups 3 and 4 included rats which received Pita orally at 0.4 and 0.8 mg/kg for 14 days after TAA injections. Renal injury increased BUN, creatinine, and MDA levels and decreased glutathione (GSH) levels. Pitavastatin prevented these alterations. TAA decreased PTEN and increased miR-93, Akt, p-Akt, mTOR, and Stat3 in the kidneys. Pitavastatin also regulated the associated culprit pathway, miR-93/PTEN/Akt/mTOR. In addition, TAA induced adverse effects on the kidney tissue, which were significantly ameliorated by pitavastatin treatment. The findings suggest that pitavastatin can attenuate renal injury, likely by regulating the miR-93/PTEN/Akt/mTOR pathway. This modulation of the pathway appears to contribute to the protective effects of pitavastatin against TAA-induced renal injury, adding to the growing evidence of the pleiotropic benefits of statins in renal health.http://dx.doi.org/10.1155/2024/6681873
spellingShingle Marawan A. Elbaset
Bassim M. S. A. Mohamed
Passant E. Moustafa
Tuba Esatbeyoglu
Sherif M. Afifi
Alyaa F. Hessin
Sahar S. Abdelrahman
Hany M. Fayed
Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway
Advances in Pharmacological and Pharmaceutical Sciences
title Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway
title_full Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway
title_fullStr Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway
title_full_unstemmed Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway
title_short Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway
title_sort renoprotective effect of pitavastatin against taa induced renal injury involvement of the mir 93 pten akt mtor pathway
url http://dx.doi.org/10.1155/2024/6681873
work_keys_str_mv AT marawanaelbaset renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway
AT bassimmsamohamed renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway
AT passantemoustafa renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway
AT tubaesatbeyoglu renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway
AT sherifmafifi renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway
AT alyaafhessin renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway
AT saharsabdelrahman renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway
AT hanymfayed renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway